Works by Habermann, Thomas


Results: 204
    1
    2
    3
    4

    A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325
    By:
    • Tolcher, Anthony;
    • Flaherty, Keith;
    • Shapiro, Geoffrey I.;
    • Berlin, Jordan;
    • Witzig, Thomas;
    • Habermann, Thomas;
    • Bullock, Andrea;
    • Rock, Edwin;
    • Elekes, Agnes;
    • Lin, Chester;
    • Kostic, Dusan;
    • Ohi, Naoto;
    • Rasco, Drew;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Smith, Lon;
    • Cote, Gregory M.
    Publication type:
    Article
    5
    6
    7

    Authors' Response.

    Published in:
    2006
    By:
    • Shanafelt, Tait;
    • West, Colin;
    • Kolars, Joseph;
    • Habermann, Thomas
    Publication type:
    Letter
    8
    9

    Risk of Lymphoma in Inflammatory Bowel Disease.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2000, v. 95, n. 9, p. 2308, doi. 10.1111/j.1572-0241.2000.02316.x
    By:
    • Loftus Jr., Edward V.;
    • Tremaine, William J.;
    • Habermann, Thomas M.;
    • Harmsen, W. Scott;
    • Zinsmeister, Alan R.;
    • Sandbom, William J.
    Publication type:
    Article
    10
    11

    Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 980, doi. 10.1002/ajh.27663
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Perera, Nirosha D.;
    • Sarosiek, Shayna;
    • Gustine, Joshua;
    • Ramirez‐Gamero, Andres;
    • Varettoni, Marzia;
    • Tedeschi, Alessandra;
    • Cavalloni, Chiara;
    • Frustaci, Anna Maria;
    • Pederson, Levi D.;
    • Zanwar, Saurabh S.;
    • Kapoor, Prashant;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Geyer, Susan M.;
    • Treon, Steven P.;
    • Castillo, Jorge J.
    Publication type:
    Article
    12

    Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 606, doi. 10.1002/ajh.27630
    By:
    • Yamshon, Samuel;
    • Koff, Jean L.;
    • Larson, Melissa C.;
    • Kahl, Brad S.;
    • Casulo, Carla;
    • Lossos, Izidore S.;
    • Haddadi, Sara;
    • Stanchina, Michele;
    • Chihara, Dai;
    • Ayers, Amy;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Khurana, Arushi;
    • Nowakowski, Grzegorz S.;
    • Reicks, Tanner W.;
    • Farooq, Umar;
    • Link, Brian K.;
    • Cohen, Jonathon B.;
    • Martin, Peter;
    • Li, Jia
    Publication type:
    Article
    13
    14

    The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
    By:
    • Cerhan, James R.;
    • Maurer, Matthew J.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Habermann, Thomas M.;
    • Jaye, David L.;
    • Burack, W. Richard;
    • McDonnell, Timothy J.;
    • Vega, Francisco;
    • Chapman, Jennifer R.;
    • Syrbu, Sergei;
    • Vij, Kiran R.;
    • Inghirami, Giorgio;
    • Leonard, John P.;
    • Bernal‐Mizrachi, Leon;
    • Farooq, Umar;
    • Witzig, Thomas E.;
    • Weiner, George J.;
    • Wang, Yucai;
    • Alderuccio, Juan P.
    Publication type:
    Article
    15
    16
    17

    Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
    By:
    • Seegobin, Karan;
    • Li, Zhuo;
    • Alhaj Moustafa, Muhamad;
    • Majeed, Umair;
    • Wang, Jing;
    • Jiang, Liuyan;
    • Kuhlman, Justin;
    • Menke, David;
    • Li, Ke;
    • Kharfan‐Dabaja, Mohamed A.;
    • Ayala, Ernesto;
    • Iqbal, Madiha;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Johnston, Patrick;
    • Thompson, Carrie;
    • Ansell, Stephen;
    • Tun, Han W.
    Publication type:
    Article
    18

    Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
    By:
    • Abdallah, Nadine H.;
    • Habermann, Thomas;
    • Buadi, Francis K.;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Dingli, David;
    • Go, Ronald S.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Kapoor, Prashant;
    • Muchtar, Eli;
    • Hwa, Yi L.;
    • Fonder, Amie L.;
    • Hobbs, Miriam A.;
    • Lin, Yi;
    • Leung, Nelson;
    • Binder, Moritz
    Publication type:
    Article
    19
    20

    Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
    By:
    • Khurana, Arushi;
    • Hathcock, Matthew;
    • Habermann, Thomas M.;
    • Al Saleh, Abdullah S.;
    • Gandhi, Sangeetha;
    • Truong, Tuan;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Johnston, Patrick B.;
    • Micallef, Ivana;
    • Lin, Yi
    Publication type:
    Article
    21

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    22

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    23

    Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
    By:
    • Higgins, Alexandra;
    • Kim, Hidong;
    • Harper, Laura;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Johnston, Patrick;
    • Witzig, Thomas E.;
    • Allmer, Cristine;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Young, Jason R.;
    • Thanarajasingam, Gita
    Publication type:
    Article
    24

    Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Durot, Eric;
    • King, Rebecca;
    • Perez Burbano, Gabriela E.;
    • Kumar, Shaji;
    • Gertz, Morie A.;
    • Quinquenel, Anne;
    • Delmer, Alain;
    • Gonsalves, Wilson;
    • Cornillet‐Lefebvre, Pascale;
    • He, Rong;
    • Warsame, Rahma;
    • Buadi, Francis K.;
    • Novak, Anne J.;
    • Greipp, Patricia T.;
    • Inwards, David;
    • Habermann, Thomas M.;
    • Micallef, Ivana;
    • Go, Ronald
    Publication type:
    Article
    25
    26
    27

    Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
    By:
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Wang, Sophia S.;
    • Maurer, Matthew J.;
    • Sarangi, Vivekananda;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Cozen, Wendy;
    • Rothman, Nathaniel;
    • Asmann, Yan;
    • Slager, Susan L.;
    • Cerhan, James R.
    Publication type:
    Article
    28

    Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
    By:
    • Castellino, Alessia;
    • Pulido, Jose S.;
    • Johnston, Patrick B.;
    • Ristow, Kay M.;
    • Nora Bennani, N.;
    • Inwards, David J.;
    • Macon, William R.;
    • Micallef, Ivana N. M.;
    • King, Rebecca L.;
    • Salomao, Diva R.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    29

    Prevalence, clinical characteristics and prognosis of EBV‐positive follicular lymphoma.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 2, p. E62, doi. 10.1002/ajh.25357
    By:
    • Mackrides, Nicholas;
    • Chapman, Jennifer;
    • Larson, Melissa C.;
    • Ramos, Juan C.;
    • Toomey, Ngoc;
    • Lin, Pei;
    • Maurer, Matthew J.;
    • Rafaelle, Myra;
    • Tan, Yaohong;
    • Ikpatt, Offiong;
    • Syrbu, Sergei;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Lossos, Izidore S.;
    • Cerhan, James R.;
    • Vega, Francisco
    Publication type:
    Article
    30

    The association of physical activity before and after lymphoma diagnosis with survival outcomes.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
    By:
    • Pophali, Priyanka A.;
    • Ip, Andrew;
    • Larson, Melissa C.;
    • Rosenthal, Allison C.;
    • Maurer, Matthew J.;
    • Flowers, Christopher R.;
    • Link, Brian K.;
    • Farooq, Umar;
    • Feldman, Andrew L.;
    • Allmer, Cristine;
    • Slager, Susan L.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Cohen, Jonathon B.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    31

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    32
    33

    Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762
    By:
    • Larsen, Jeremy T.;
    • Shanafelt, Tait D.;
    • Leis, Jose F.;
    • LaPlant, Betsy;
    • Call, Tim;
    • Pettinger, Adam;
    • Hanson, Curtis;
    • Erlichman, Charles;
    • Habermann, Thomas Matthew;
    • Reeder, Craig;
    • Nikcevich, Daniel;
    • Bowen, Deborah;
    • Conte, Michael;
    • Boysen, Justin;
    • Secreto, Charla;
    • Lesnick, Connie;
    • Tschumper, Renee;
    • Jelinek, Diane;
    • Kay, Neil E.;
    • Ding, Wei
    Publication type:
    Article
    34

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    35

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    36
    37
    38

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    39
    40

    Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 6, p. 639, doi. 10.1002/ajh.23709
    By:
    • Gustafson, Heather L.;
    • Yao, Song;
    • Goldman, Bryan H.;
    • Lee, Kristy;
    • Spier, Catherine M.;
    • LeBlanc, Michael L.;
    • Rimsza, Lisa M.;
    • Cerhan, James R.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Maurer, Matthew J.;
    • Slager, Susan L.;
    • Persky, Daniel O.;
    • Miller, Thomas P.;
    • Fisher, Richard I.;
    • Ambrosone, Christine B.;
    • Briehl, Margaret M.
    Publication type:
    Article
    41

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    42

    The clinical spectrum of Castleman's disease.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 11, p. 997, doi. 10.1002/ajh.23291
    By:
    • Dispenzieri, Angela;
    • Armitage, James O.;
    • Loe, Matt J.;
    • Geyer, Susan M.;
    • Allred, Jake;
    • Camoriano, John K.;
    • Menke, David M.;
    • Weisenburger, Dennis D.;
    • Ristow, Kay;
    • Dogan, Ahmet;
    • Habermann, Thomas M.
    Publication type:
    Article
    43
    44
    45
    46

    Inherited genetic variation and overall survival following follicular lymphoma.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 7, p. 724, doi. 10.1002/ajh.23184
    By:
    • Gibson, Todd M.;
    • Wang, Sophia S.;
    • Cerhan, James R.;
    • Maurer, Matthew J.;
    • Hartge, Patricia;
    • Habermann, Thomas M.;
    • Davis, Scott;
    • Cozen, Wendy;
    • Lynch, Charles F.;
    • Severson, Richard K.;
    • Rothman, Nathaniel;
    • Chanock, Stephen J.;
    • Morton, Lindsay M.
    Publication type:
    Article
    47
    48
    49
    50